<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01180803</url>
  </required_header>
  <id_info>
    <org_study_id>EVAL- CLIN A00690-39</org_study_id>
    <nct_id>NCT01180803</nct_id>
  </id_info>
  <brief_title>Efficacy of Oxygen Therapy Delivered by Systems Using Oxygen-Saving Valves in COPD Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the efficacy of oxygen therapy delivered by systems
      using oxygen-saving valves or not (continuous oxygen). We aim to determine if systems using
      oxygen-saving valves are equally effective as continuous oxygen delivery systems in reducing
      exercise-induced hypoxemia in patients with COPD.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>oxygen saturation during 6 minutes walking test</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Walking distance during the 6 minutes walking test</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>LUNG DISEASES, OBSTRUCTIVE</condition>
  <arm_group>
    <arm_group_label>oxygen-saving valves</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>continuous oxygen supplementation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>pulse oxygen supplementation devices</intervention_name>
    <description>oxygen therapy delivered by systems using oxygen-saving valves</description>
    <arm_group_label>oxygen-saving valves</arm_group_label>
    <other_name>pulse group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>continuous oxygen</intervention_name>
    <description>oxygen therapy delivered by continuous liquid oxygen devices</description>
    <arm_group_label>continuous oxygen supplementation</arm_group_label>
    <other_name>continuous group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COPD on necessity of long term oxygen therapy

          -  Able to give their written consent

        Exclusion Criteria:

          -  Unstable patients with COPD

          -  Patients with restrictive respiratory disease

          -  Patients with cardiac or neurologic disease contre-indicating the different
             evaluations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Boris MELLONI, Pr</last_name>
    <phone>+33 1. 56. 81. 40. 60</phone>
    <email>melloni@unilim.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fédération ANTADIR</name>
      <address>
        <city>Paris</city>
        <zip>75006</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacqueline DELRIEU, Ph. D</last_name>
      <phone>+33.1.56.81.40.60</phone>
      <email>delrieu@antadir.com</email>
    </contact>
    <investigator>
      <last_name>Boris MELLONI, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2010</study_first_submitted>
  <study_first_submitted_qc>August 11, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 12, 2010</study_first_posted>
  <last_update_submitted>November 20, 2017</last_update_submitted>
  <last_update_submitted_qc>November 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche</investigator_affiliation>
    <investigator_full_name>DELRIEU Jacqueline</investigator_full_name>
    <investigator_title>Clinical Project Manager</investigator_title>
  </responsible_party>
  <keyword>COPD - long term oxygenotherapy</keyword>
  <keyword>COPD patients with respiratory failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

